23/04/2020 - Institutional news
The Scientific Advisory Board (SAB) is made up of a group of prestigious international scientists, experts in the different areas corresponding to the IMIM research programs. Until very recently the president of the SAB was Dr. Joaquin Arribas, but with his incorporation as director of the IMIM and scientific director of the PSMAR, will take his place Dr. Xosé R. Bustelo, Deputy Director of the Cancer Research Center (CIC), University of Salamanca-CSIC, Director of the Genomics and Proteomics Unit and coordinator of the Tumor Progression Mechanisms Program at the same center. He is also a member of the CIBERONC Steering Committee. Dr. Bustelo holds a PhD in Biology from the University of Santiago de Compostela, his scientific training includes several stays at international research centers such as the Bristol Myers Squibb Pharmaceutical Research Institute (Princeton, New Jersey, USA), as a postdoctoral fellow and later as Research Scientist and in the Department of Pathology at State University of New York (Stony Brook, New York, USA, as an Assistant Professor.
Més informació "New chairman of the IMIM External Scientific Advisory Board"
The IMIM Clinical Metabolomics Platform led by Dr. Oscar J. Pozo, from the IMIM Integrated Pharmacology and Systems Neuroscience Research Group, has become part of the EATRIS consortium, the European infrastructure for translational medicine, as part of the biomarker platform. This means that the IMIM is now part of a consortium comprising more than 80 prestigious European institutes that is aiming to establish synergies between healthcare researchers by providing them with the most advanced technologies and the experience needed to make headway in translational medicine. EATRIS is a European Research Infrastructure Consortium (ERIC) whose main objective is to advance translational medicine. Translational research is a highly multidisciplinary and complex undertaking. One of the greatest challenges in innovation is to understand which steps are necessary and the most appropriate technology and knowledge for taking these steps.
19/03/2020 - Institutional news
The IMIM Foundation announces one position for a Recognised Researcher (R4) with the objective of incorporating into the Institute a researcher of excellence, a leader of research in his/her field, and of international prestige in the field of Biomedicine. The incorporation of the candidate should add significant value to the Institute and make a notable contribution towards achieving the Institute's strategic objectives. Researchers from competitive programmes, such as the Ramón y Cajal and similar programmes, who have made exceptional contributions, will be considered. The candidate must have a PhD in the field of Biomedicine and an exceptional research career, with an excellent leadership capacity and proven international experience in one of the IMIM Foundation's research programmes: Cancer, Epidemiology and Public Health, Inflammatory and Cardiovascular Disorders, Biomedical Informatics, or Neurosciences.
Més informació "Call for one position for Recognised Researcher (R4)"
17/03/2020 - Institutional news
Following the state of alarm declared throughout Spain due to COVID-19 and the recommendations of the Catalan authorities to collaborate in preventing the spread of COVID-19, from Monday March 16th onwards, the IMIM staff will be teleworking and will be able to assist you via email and/or telephone. If you have any doubts or questions, you can contact us through the general form on the website: https://www.imim.es/en_contacte.html or by writing to the email addresses of the research areas and groups that are listed on that website.
20/01/2020 - Institutional news
Joaquín Arribas is an ICREA Research Professor at the Vall d'Hebron Institute of Oncology (VHIO) and Scientific Director at CIBERONC. He studied biochemistry at the Universidad Autónoma de Madrid (1987) where he later worked on the regulation of proteasome catalytic activities and got his PhD in Biology (1991). Sponsored by a grant from the Ministry of Education and Science, he joined the Memorial Sloan-Kettering Cancer Center in New York (USA) as a postdoctoral fellow with Joan Massagué (1992-96), where he worked on the proteolytic processing of transmembrane growth factors. In 1997 he joined the Department of Oncological Research at Vall d'Hebron Hospital in Barcelona, since which time he has been directing the Growth Factors group. In 2010, he was appointed director of the VHIO preclinical research programme, and in 2017 he became the scientific director at CIBERONC. His research has been recognised by the EMBO Young Investigator Programme Beckman Coultek Award, given to the best Spanish researcher in Biochemistry and Molecular Biology.
Més informació "Dr. Joaquín Arribas, new PSMAR research director and IMIM director"
16/01/2020 - Institutional news
The global organisation Worldwide Cancer Research, based in Scotland, will fund a three-year breast cancer metastasis study by Toni Celià-Terrassa, from the IMIM's Molecular Cancer Therapy Research Group. The project aims to explore the dynamics and behaviour of tumour populations that undergo epithelial-mesenchymal transition (EMT) during breast cancer metastasis. For this purpose, advanced 3D microscopy and single-cell transcriptomic techniques will be used in conjunction with computational biology analysis.
Més informació "Worldwide Cancer Research sponsors a breast cancer metastasis project at the IMIM"
29/10/2019 - Institutional news
The high levels of environmental noise we are subjected to in large cities can increase both the severity and consequences of an ischaemic stroke. More precisely, researchers from the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar, together with researchers from the Barcelona Institute for Global Health (ISGlobal), CIBER in Epidemiology and Public Health (CIBERESP), and Brown University, in the United States, put the increased risk at 30% for people living in noisier areas. In contrast, living close to green areas brings down this risk by up to 25%. This is the first time that these factors have been analysed in relation to stroke severity. The study has been published in the journal Environmental Research.
Més informació "Living in a noisy area increases the risk of suffering a more serious stroke"
05/04/2019 - Institutional news
Provisional relationship of advice and excluded aspirant persons that have been submitted to the external call for the merits competition, for the provision of a job of HUMAN RESOURCES DIRECTOR Mar Institute of Medical Research Foundation Managing body of the Hospital del Mar Medical Research Institute (IMIM) (Call FIMIM_01/2019).
22/03/2019 - Institutional news
In relation to the HOSPITAL RESOURCES DIRECTOR OF HUMAN RESOURCES Institut Mar d'investigacions Mèdiques Foundation, managing entity of the Hospital del Mar Institute for Medical Research. (call FIMIM_01 / 2019), the deadline for submitting candidatures is extended until March 28, 2019.
18/02/2019 - Institutional news
The Mar Institute of Medical Research Foundation (IMIM Foundation), announces the position of Director with incorporation through a full-time work contract and appointment as Director. The person awarded the position will be responsible for developing and implementing policies related to staff effectiveness, aligned with the Institute's strategy. Their main role will be to ensure that the people who work in the Institute have a balance between skills and experience, fostering their development so that they have the opportunity to improve their position within the Institute itself. They must always generate a supportive and challenging work environment that promotes equal opportunities, ethical integrity, and a work-life balance.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
